© 2022 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#EASL 2018

Anthony Tan, EASL 2018
Personalized Immunotherapy Shows Promise for Liver Cancer
52nd International Liver Congress Roundup
Click Here for More Conferences
Jens Ricke speaks at EASL International Liver Congress

Local Therapies With Nexavar Do Not Improve Liver Cancer Survival

Adding internal radiation or TACE did appear to help certain people, however.

Curing Hepatitis C Is Associated With a Reduced Risk of Death

This is according to an analysis of nearly 5,000 Italians recently treated for the virus.

Treating Hep C Earlier Likely Saves Money, Improves Health Outlook

This is according to a recent mathematical modeling study.
EASL 2018 social media lounge

Reporter’s Notebook: International Liver Congress Sees Shift in Liver Diseases

Hepatitis B and C are declining as causes of liver cancer and liver transplants.
EASL liver cancer guidelines panel at International Liver Congress

EASL Updates Liver Cancer Guidelines

Recommendations now include multiple systemic medications in addition to surgery and local therapies.
Advertisement
Features
Newsfeed

Cancer Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

Cancer Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.